Beacon Pointe Advisors, LLC Dexcom Inc Transaction History

Beacon Pointe Advisors, LLC

$11.3 Billion
Q3 2025

A detailed history of Beacon Pointe Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 6,012 shares of DXCM stock, worth $349,056. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,012

Previous 7,721 22.13%

Holding current value

$349,056

Previous $673,000 39.97%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$66.46 - $89.53 $113,580 - $153,006	-1,709 Reduced 22.13%	6,012 $404,000
Q2 2025 Aug 13, 2025	SELL	$59.83 - $87.57 $32,607 - $47,725	-545 Reduced 6.59%	7,721 $673,000
Q1 2025 May 13, 2025	SELL	$67.74 - $90.75 $651,726 - $873,105	-9,621 Reduced 53.79%	8,266 $564,000
Q4 2024 Feb 14, 2025	SELL	$65.68 - $81.01 $186,465 - $229,987	-2,839 Reduced 13.7%	17,887 $1.39 Million
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $175,936 - $319,048	-2,749 Reduced 11.71%	20,726 $1.39 Million

Q2 2024 Aug 12, 2024	SELL	$110.31 - $140.45 $19,083 - $24,297	-173 Reduced 0.73%	23,475 $2.66 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $29,582 - $36,285	-259 Reduced 1.08%	23,648 $3.28 Million
Q4 2023 Feb 08, 2024	SELL	$75.49 - $124.16 $78,660 - $129,374	-1,042 Reduced 4.18%	23,907 $2.97 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $62,909 - $100,826	731 Added 3.02%	24,949 $2.33 Million
Q2 2023 Aug 11, 2023	SELL	$112.47 - $130.98 $8,097 - $9,430	-72 Reduced 0.3%	24,218 $3.11 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $520 - $614	5 Added 0.02%	24,290 $2.82 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $114,383 - $165,113	1,346 Added 5.87%	24,285 $2.75 Million
Q3 2022 Nov 09, 2022	BUY	$76.35 - $94.18 $27,485 - $33,904	360 Added 1.59%	22,939 $1.85 Million
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $1.14 Million - $2.23 Million	16,790 Added 290.03%	22,579 $1.69 Million
Q1 2022 May 17, 2022	BUY	$94.08 - $130.2 $46,381 - $64,188	493 Added 9.31%	5,789 $2.96 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $118,831 - $148,980	-915 Reduced 14.73%	5,296 $2.84 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $440,178 - $590,617	4,125 Added 197.75%	6,211 $3.4 Million
Q2 2021 Aug 17, 2021	BUY	$80.99 - $107.93 $168,945 - $225,141	2,086 New	2,086 $891,000

Others Institutions Holding DXCM

# of Institutions

1,086

Shares Held

377M

Call Options Held

6.76M

Put Options Held

7.24M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Account

Beacon Pointe Advisors, LLC Dexcom Inc Transaction History